Sandbox:Kashvi Gupta: Difference between revisions
Jump to navigation
Jump to search
Line 34: | Line 34: | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
|''' | |'''Gastroenterologic''' | ||
| bgcolor="Beige" |No underlying causes | | bgcolor="Beige" |No underlying causes | ||
|- | |- | ||
Line 50: | Line 50: | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
|'''Infectious Disease''' | |'''Infectious [[Disease]]''' | ||
| bgcolor="Beige" |No underlying causes | | bgcolor="Beige" |No underlying causes | ||
|- | |- |
Latest revision as of 13:58, 2 October 2020
Overview
Therapy for hemolytic uremic syndrome (HUS) is supportive therapy.
Causes by Organ System
Kashvi Gupta[1]
Cardiovascular | No underlying causes |
Chemical / poisoning | No underlying causes |
Dermatologic | No underlying causes |
Drug Side Effect | No underlying causes |
Ear Nose Throat | No underlying causes |
Endocrine | No underlying causes |
Environmental | No underlying causes |
Gastroenterologic | No underlying causes |
Genetic | No underlying causes |
Hematologic | No underlying causes |
Iatrogenic | No underlying causes |
Infectious Disease | No underlying causes |
Musculoskeletal / Ortho | No underlying causes |
Neurologic | No underlying causes |
Nutritional / Metabolic | No underlying causes |
Obstetric/Gynecologic | No underlying causes |
Oncologic | No underlying causes |
Opthalmologic | No underlying causes |
Overdose / Toxicity | No underlying causes |
Psychiatric | No underlying causes |
Pulmonary | No underlying causes |
Renal / Electrolyte | No underlying causes |
Rheum / Immune / Allergy | No underlying causes |
Sexual | No underlying causes |
Trauma | No underlying causes |
Urologic | No underlying causes |
Dental | No underlying causes |
Miscellaneous | No underlying causes |
Treatment
Pharmacotherapy
Acute Pharmacotherapies
Chronic Pharmacotherapies
References
- ↑ Wells, Samuel A.; Pacini, Furio; Robinson, Bruce G.; Santoro, Massimo (2013). "Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update". The Journal of Clinical Endocrinology & Metabolism. 98 (8): 3149–3164. doi:10.1210/jc.2013-1204. ISSN 0021-972X.